| scholarly article | Q13442814 |
| P50 | author | Valentina Sancisi | Q42533055 |
| Alessia Ciarrocchi | Q42533058 | ||
| Simonetta Piana | Q88792714 | ||
| Ione Tamagnini | Q114429038 | ||
| Davide Nicoli | Q114429047 | ||
| Moira Ragazzi | Q114576775 | ||
| P2093 | author name string | Sally Maramotti | |
| Gloria Borettini | |||
| P2860 | cites work | Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter | Q24537942 |
| Id proteins in development, cell cycle and cancer | Q28190570 | ||
| Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells | Q28204395 | ||
| Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation | Q28240596 | ||
| Runx2 controls a feed-forward loop between androgen and prolactin-induced protein (PIP) in stimulating T47D cell proliferation | Q28244711 | ||
| Tollip is a mediator of protein sumoylation | Q28569172 | ||
| Matrix metalloproteinases: regulators of the tumor microenvironment | Q29619858 | ||
| Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions | Q30435146 | ||
| The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion | Q30447945 | ||
| Thyroid cancer survival in the United States: observational data from 1973 to 2005. | Q33579885 | ||
| The bone-specific expression of Runx2 oscillates during the cell cycle to support a G1-related antiproliferative function in osteoblasts | Q33953806 | ||
| The cancer-related Runx2 protein enhances cell growth and responses to androgen and TGFbeta in prostate cancer cells. | Q34078444 | ||
| Frequent attenuation of the WWOX tumor suppressor in osteosarcoma is associated with increased tumorigenicity and aberrant RUNX2 expression | Q34570006 | ||
| Cancer-related ectopic expression of the bone-related transcription factor RUNX2 in non-osseous metastatic tumor cells is linked to cell proliferation and motility | Q34989177 | ||
| FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion | Q35024427 | ||
| Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion | Q35669749 | ||
| Genomic promoter occupancy of runt-related transcription factor RUNX2 in Osteosarcoma cells identifies genes involved in cell adhesion and motility | Q35762938 | ||
| MT1-MMP: a potent modifier of pericellular microenvironment. | Q36141763 | ||
| Advances in Runx2 regulation and its isoforms | Q36562392 | ||
| Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone. | Q36682092 | ||
| The impact of distant metastases at presentation on prognosis in patients with differentiated carcinoma of the thyroid gland. | Q37022492 | ||
| Co-stimulation of the bone-related Runx2 P1 promoter in mesenchymal cells by SP1 and ETS transcription factors at polymorphic purine-rich DNA sequences (Y-repeats) | Q37075344 | ||
| Positive association between nuclear Runx2 and oestrogen-progesterone receptor gene expression characterises a biological subtype of breast cancer. | Q37323255 | ||
| Ectopic runx2 expression in mammary epithelial cells disrupts formation of normal acini structure: implications for breast cancer progression | Q37343805 | ||
| Integration of BMP, Wnt, and notch signaling pathways in osteoblast differentiation. | Q37906474 | ||
| Runx2 regulates G protein-coupled signaling pathways to control growth of osteoblast progenitors | Q38289269 | ||
| Dlx5 specifically regulates Runx2 type II expression by binding to homeodomain-response elements in the Runx2 distal promoter | Q38321841 | ||
| Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis | Q38340672 | ||
| The osteoblast transcription factor Runx2 is expressed in mammary epithelial cells and mediates osteopontin expression. | Q38350119 | ||
| Inhibitor of DNA binding-1 induces mesenchymal features and promotes invasiveness in thyroid tumour cells. | Q39621813 | ||
| Glucose-activated RUNX2 phosphorylation promotes endothelial cell proliferation and an angiogenic phenotype | Q39959730 | ||
| Expression and function of Cbfa-1/Runx2 in thyroid papillary carcinoma cells | Q39996177 | ||
| Constitutive expression and regulation of collagenase-3 in human breast cancer cells. | Q40868944 | ||
| Description of a human papillary thyroid carcinoma cell line. Morphologic study and expression of tumoral markers | Q41474200 | ||
| Runx2 deficiency in mice causes decreased thyroglobulin expression and hypothyroidism | Q42058727 | ||
| Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha | Q42513418 | ||
| Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. | Q42826927 | ||
| Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. | Q53923828 | ||
| Runx2 in human breast carcinoma: its potential roles in cancer progression | Q54643065 | ||
| Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness. | Q54655522 | ||
| Management guidelines for patients with thyroid nodules and differentiated thyroid cancer | Q82293286 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | E2006-15 | |
| P577 | publication date | 2012-07-20 | |
| P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| P1476 | title | Runx2 isoform I controls a panel of proinvasive genes driving aggressiveness of papillary thyroid carcinomas | |
| P478 | volume | 97 |
| Q37375359 | Aberrant expression of posterior HOX genes in well differentiated histotypes of thyroid cancers |
| Q39032755 | Autophagy and epithelial-mesenchymal transition: an intricate interplay in cancer |
| Q37708464 | CXCL12 methylation-mediated epigenetic regulation of gene expression in papillary thyroid carcinoma |
| Q34999638 | Cadherin 6 is a new RUNX2 target in TGF-β signalling pathway |
| Q47248660 | Cadherin 6 is activated by Epstein-Barr virus LMP1 to mediate EMT and metastasis as an interplay node of multiple pathways in nasopharyngeal carcinoma |
| Q36067156 | Cadherin-6 promotes EMT and cancer metastasis by restraining autophagy |
| Q102213210 | Gene expression profile unveils diverse biological effect of serum VitaminD in Hodgkin's and Diffuse Large B-Cell Lymphoma |
| Q92504777 | HDACs control RUNX2 expression in cancer cells through redundant and cell context-dependent mechanisms |
| Q88636947 | Integrated bioinformatics analysis reveals that the expression of cathepsin S is associated with lymph node metastasis and poor prognosis in papillary thyroid cancer |
| Q113223927 | Novel lncRNA LINC01614 Facilitates Bladder Cancer Proliferation, Migration and Invasion Through the miR-217/RUNX2/Wnt/β-Catenin Axis |
| Q26800112 | RUNX2 and the PI3K/AKT axis reciprocal activation as a driving force for tumor progression |
| Q47692014 | RUNX2 expression in thyroid and breast cancer requires the cooperation of three non-redundant enhancers under the control of BRD4 and c-JUN. |
| Q45762060 | Redefining the activity of a bone-specific transcription factor: novel insights for understanding bone formation |
| Q48301345 | Runt-Related Transcription Factor 2 (Runx2) Is Responsible for Galectin-3 Overexpression in Human Thyroid Carcinoma. |
| Q48194394 | Runx2, an inducer of osteoblast and chondrocyte differentiation. |
| Q92578198 | The Hippo pathway modulates resistance to BET proteins inhibitors in lung cancer cells |
| Q58695682 | The bHLH transcription factor DEC1 promotes thyroid cancer aggressiveness by the interplay with NOTCH1 |
| Q90536694 | The significance of Runx2 mediating alcohol-induced Brf1 expression and RNA Pol III gene transcription |
| Q88639338 | Thyroid Hormone Receptor β Suppression of RUNX2 Is Mediated by Brahma-Related Gene 1-Dependent Chromatin Remodeling |
| Q38766996 | Thyroid Hormone Receptor-β (TRβ) Mediates Runt-Related Transcription Factor 2 (Runx2) Expression in Thyroid Cancer Cells: A Novel Signaling Pathway in Thyroid Cancer |
| Q64077103 | Transcription Factor HOXA9 is Linked to the Calcification and Invasion of Papillary Thyroid Carcinoma |
| Q57490424 | overexpression suppresses tumorigenesis of papillary thyroid cancer via inactivation of PTEN/PI3K/AKT pathway by targeting Runx2 |
Search more.